摘要
PCR法扩增FⅦ基因,构建重组表达质粒FⅦ-pOptiVEC,酶切、测序鉴定.脂质体法将FⅦ-pOptiVEC质粒转入CHO/DG44细胞,并用氨甲喋呤(MTX)进行分级加压筛选,获得高表达重组FⅦ蛋白的阳性细胞克隆.亲和层析法纯化FⅦ,并通过Western-blot检测蛋白表达情况.采用FⅦ促凝活性检测试剂盒(凝固法)检测FⅦ的凝血活性.结果表明筛选出的细胞克隆能稳定表达目的蛋白,MTX加压使其表达量明显升高.促凝活性检测结果证明获得的FⅦ蛋白具有凝血活性.
FⅦ gene was amplified by PCR and inserted into pOptiVEC vector. Then the recombinant plasmid was transfected into CHO/DG44 cells after being identified by enzyme digestion and sequencing. The obtained positive clones were further screened at different concentrations of MTX. FⅦ protein was purified by affinity chromatography and confirmed by Western-blot and PT. The Results showed that the recombinant plasmid was construct correctly and the positive cell clones could steadily express F Ⅶ which had the coagulation activity.
出处
《四川大学学报(自然科学版)》
CAS
CSCD
北大核心
2015年第3期673-676,共4页
Journal of Sichuan University(Natural Science Edition)
基金
国家自然科学基金项目(31371325)
关键词
人凝血因子Ⅶ
真核表达
CHO/DG44细胞
凝血活性
Human coagulation factorⅦ (FⅦ), eukaryotic expression, CHO/DG44 cell,coagulation ac-tivity